BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 35908087)

  • 1. Ym155 localizes to the mitochondria leading to mitochondria dysfunction and activation of AMPK that inhibits BMP signaling in lung cancer cells.
    Mondal A; Jia D; Bhatt V; Akel M; Roberge J; Guo JY; Langenfeld J
    Sci Rep; 2022 Jul; 12(1):13135. PubMed ID: 35908087
    [TBL] [Abstract][Full Text] [Related]  

  • 2. YM155, a small molecule inhibitor of survivin expression, sensitizes cancer cells to hypericin-mediated photodynamic therapy.
    Gyurászová K; Mikeš J; Halaburková A; Jendželovský R; Fedoročko P
    Photochem Photobiol Sci; 2016 Jun; 15(6):812-21. PubMed ID: 27241169
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Bone morphogenetic protein inhibitors and mitochondria targeting agents synergistically induce apoptosis-inducing factor (AIF) caspase-independent cell death in lung cancer cells.
    Mondal A; Roberge J; Gilleran J; Peng Y; Jia D; Akel M; Patel Y; Zoltowski H; Doraiswamy A; Langenfeld J
    Cell Commun Signal; 2022 Jun; 20(1):99. PubMed ID: 35761398
    [TBL] [Abstract][Full Text] [Related]  

  • 4. YM155 sensitizes non-small cell lung cancer cells to EGFR-tyrosine kinase inhibitors through the mechanism of autophagy induction.
    Dai CH; Shu Y; Chen P; Wu JN; Zhu LH; Yuan RX; Long WG; Zhu YM; Li J
    Biochim Biophys Acta Mol Basis Dis; 2018 Dec; 1864(12):3786-3798. PubMed ID: 30315932
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Commitment toward cell death by activation of autophagy with survivin inhibitor YM155 in two canine squamous cell carcinoma cell lines with high expression of survivin.
    Miyamoto R; Tani H; Ikeda T; Saima H; Tamura K; Bonkobara M
    Res Vet Sci; 2021 Mar; 135():412-415. PubMed ID: 33160684
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dual induction of apoptotic and autophagic cell death by targeting survivin in head neck squamous cell carcinoma.
    Zhang L; Zhang W; Wang YF; Liu B; Zhang WF; Zhao YF; Kulkarni AB; Sun ZJ
    Cell Death Dis; 2015 May; 6(5):e1771. PubMed ID: 26018732
    [TBL] [Abstract][Full Text] [Related]  

  • 7. YM155 induces EGFR suppression in pancreatic cancer cells.
    Na YS; Yang SJ; Kim SM; Jung KA; Moon JH; Shin JS; Yoon DH; Hong YS; Ryu MH; Lee JL; Lee JS; Kim TW
    PLoS One; 2012; 7(6):e38625. PubMed ID: 22723871
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antitumor effect of YM155, a novel small-molecule survivin suppressant, via mitochondrial apoptosis in human MFH/UPS.
    Minoda M; Kawamoto T; Ueha T; Kamata E; Morishita M; Harada R; Toda M; Onishi Y; Hara H; Kurosaka M; Akisue T
    Int J Oncol; 2015 Sep; 47(3):891-9. PubMed ID: 26166250
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Targeting of Survivin Pathways by YM155 Inhibits Cell Death and Invasion in Oral Squamous Cell Carcinoma Cells.
    Zhang W; Liu Y; Li YF; Yue Y; Yang X; Peng L
    Cell Physiol Biochem; 2016; 38(6):2426-37. PubMed ID: 27287458
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Survivin inhibitor YM155 induces mitochondrial dysfunction, autophagy, DNA damage and apoptosis in Bcl-xL silenced glioma cell lines.
    Jane EP; Premkumar DR; Sutera PA; Cavaleri JM; Pollack IF
    Mol Carcinog; 2017 Apr; 56(4):1251-1265. PubMed ID: 27805285
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cellular inhibitor of apoptosis protein 1 (cIAP1) stability contributes to YM155 resistance in human gastric cancer cells.
    Jung SA; Park YM; Hong SW; Moon JH; Shin JS; Lee HR; Ha SH; Lee DH; Kim JH; Kim SM; Kim JE; Kim KP; Hong YS; Choi EK; Lee JS; Jin DH; Kim T
    J Biol Chem; 2015 Apr; 290(16):9974-85. PubMed ID: 25635055
    [TBL] [Abstract][Full Text] [Related]  

  • 12. YM155 down-regulates survivin and XIAP, modulates autophagy and induces autophagy-dependent DNA damage in breast cancer cells.
    Cheng SM; Chang YC; Liu CY; Lee JY; Chan HH; Kuo CW; Lin KY; Tsai SL; Chen SH; Li CF; Leung E; Kanwar JR; Huang CC; Chang JY; Cheung CH
    Br J Pharmacol; 2015 Jan; 172(1):214-34. PubMed ID: 25220225
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Survivin selective inhibitor YM155 induce apoptosis in SK-NEP-1 Wilms tumor cells.
    Tao YF; Lu J; Du XJ; Sun LC; Zhao X; Peng L; Cao L; Xiao PF; Pang L; Wu D; Wang N; Feng X; Li YH; Ni J; Wang J; Pan J
    BMC Cancer; 2012 Dec; 12():619. PubMed ID: 23267699
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Autophagic HuR mRNA degradation induces survivin and MCL1 downregulation in YM155-treated human leukemia cells.
    Chiou JT; Lee YC; Huang CH; Shi YJ; Wang LJ; Chang LS
    Toxicol Appl Pharmacol; 2020 Jan; 387():114857. PubMed ID: 31837377
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Preclinical efficacy of sepantronium bromide (YM155) in multiple myeloma is conferred by down regulation of Mcl-1.
    Wagner V; Hose D; Seckinger A; Weiz L; Meißner T; Rème T; Breitkreutz I; Podar K; Ho AD; Goldschmidt H; Krämer A; Klein B; Raab MS
    Oncotarget; 2014 Nov; 5(21):10237-50. PubMed ID: 25296978
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Small molecule inhibitor YM155-mediated activation of death receptor 5 is crucial for chemotherapy-induced apoptosis in pancreatic carcinoma.
    Zhao X; Puszyk WM; Lu Z; Ostrov DA; George TJ; Robertson KD; Liu C
    Mol Cancer Ther; 2015 Jan; 14(1):80-9. PubMed ID: 25344582
    [TBL] [Abstract][Full Text] [Related]  

  • 17. YM155 induces apoptosis through downregulation of specificity protein 1 and myeloid cell leukemia-1 in human oral cancer cell lines.
    Sachita K; Yu HJ; Yun JW; Lee JS; Cho SD
    J Oral Pathol Med; 2015 Nov; 44(10):785-91. PubMed ID: 25475012
    [TBL] [Abstract][Full Text] [Related]  

  • 18. YM155 Down-Regulates Survivin and Induces P53 Up-Regulated Modulator of Apoptosis (PUMA)-Dependent in Oral Squamous Cell Carcinoma Cells.
    Yan X; Su H
    Med Sci Monit; 2017 Apr; 23():1963-1972. PubMed ID: 28435150
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Early Cellular Responses of Prostate Carcinoma Cells to Sepantronium Bromide (YM155) Involve Suppression of mTORC1 by AMPK.
    Danielpour D; Gao Z; Zmina PM; Shankar E; Shultes BC; Jobava R; Welford SM; Hatzoglou M
    Sci Rep; 2019 Aug; 9(1):11541. PubMed ID: 31395901
    [TBL] [Abstract][Full Text] [Related]  

  • 20. YM155 inhibits tumor growth and enhances chemosensitivity to cisplatin in osteosarcoma.
    Gao JZ; Chen FH; Wang L; Wei H; Meng SL
    Eur Rev Med Pharmacol Sci; 2015; 19(11):2062-9. PubMed ID: 26125270
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.